苑东生物
(688513)
| 流通市值：59.19亿 | | | 总市值：59.19亿 |
| 流通股本：1.77亿 | | | 总股本：1.77亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,039,937,156.56 | 669,513,693.52 | 314,990,089.28 | 1,117,120,749.58 |
| 营业收入 | 1,039,937,156.56 | 669,513,693.52 | 314,990,089.28 | 1,117,120,749.58 |
| 二、营业总成本 | 858,787,446.13 | 543,480,539.83 | 258,240,843.28 | 951,862,398.84 |
| 营业成本 | 233,451,947.3 | 149,126,238.02 | 63,554,482.38 | 223,274,090.2 |
| 税金及附加 | 15,744,472.83 | 10,347,928.72 | 4,933,061.25 | 17,825,701.97 |
| 销售费用 | 353,893,867.87 | 236,568,520.74 | 115,644,087.01 | 384,561,616.09 |
| 管理费用 | 73,056,791.44 | 43,469,812.24 | 20,868,865.41 | 98,866,793.87 |
| 研发费用 | 188,129,351.01 | 108,931,264.31 | 54,184,914.96 | 238,490,518.55 |
| 财务费用 | -5,488,984.32 | -4,963,224.2 | -944,567.73 | -11,156,321.84 |
| 其中:利息费用 | 2,977,621.7 | 2,181,191.13 | 976,428.73 | 3,417,921.96 |
| 其中:利息收入 | 8,357,080.35 | 6,876,759.49 | 2,063,336.49 | 14,696,057.77 |
| 加:公允价值变动收益 | 13,500,280.18 | 9,099,774.42 | 3,158,836.5 | 14,566,568.73 |
| 加:投资收益 | 4,791,902.45 | 4,593,293.23 | 3,133,484.49 | 10,910,158.34 |
| 资产处置收益 | -2,294.24 | -2,294.24 | -2,294.24 | 133,286.31 |
| 资产减值损失(新) | -1,740,562.67 | -669,631.16 | -178,857.05 | -2,626,552.77 |
| 信用减值损失(新) | -5,915,009.12 | -5,417,544.21 | -2,312,081.71 | 384,480.59 |
| 其他收益 | 39,768,199.3 | 25,954,090.1 | 19,672,640.66 | 53,110,690.06 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 231,552,226.33 | 159,590,841.83 | 80,220,974.65 | 241,736,982 |
| 加:营业外收入 | 9,351.68 | 679.27 | 269.18 | 104,220 |
| 减:营业外支出 | 192,367.83 | 135,164.65 | 129,971.22 | 201,545.82 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 231,369,210.18 | 159,456,356.45 | 80,091,272.61 | 241,639,656.18 |
| 减:所得税费用 | 14,345,612.26 | 12,964,003.58 | 5,081,187.65 | 15,065,235.61 |
| 六、净利润 | 217,023,597.92 | 146,492,352.87 | 75,010,084.96 | 226,574,420.57 |
| 持续经营净利润 | 217,023,597.92 | 146,492,352.87 | 75,010,084.96 | 226,574,420.57 |
| 归属于母公司股东的净利润 | 217,023,597.92 | 146,492,352.87 | 75,010,084.96 | 226,574,420.57 |
| (一)基本每股收益 | 1.24 | 0.83 | 0.63 | 1.89 |
| (二)稀释每股收益 | 1.24 | 0.83 | 0.63 | 1.89 |
| 九、综合收益总额 | 217,023,597.92 | 146,492,352.87 | 75,010,084.96 | 226,574,420.57 |
| 归属于母公司股东的综合收益总额 | 217,023,597.92 | 146,492,352.87 | 75,010,084.96 | 226,574,420.57 |
| 公告日期 | 2024-10-25 | 2024-08-20 | 2024-04-23 | 2024-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |